Chiara Morelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chiara Morelli has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Paolo Arosio
Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, 8093, Zurich, Switzerland
6 shared publications Marcell Papp
ETH Zürich, Department of Chemical and Applied Biosciences Institute for Chemical and Bioengineering Zürich Switzerland
4 shared publicationsLenka Faltova
Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zürich, Zurich, Switzerland
3 shared publicationsKatarzyna Makasewicz
Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland
2 shared publications- Katarzyna Makasewicz
ETH Zurich
2 shared publications Sarah Khawaja
ETH Zürich, Department of Chemical and Applied Biosciences Institute for Chemical and Bioengineering Zürich Switzerland
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (33) , e15409
Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates
Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.
- 26 June 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (33) , e15409
Open AccessInhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates
Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.
- Open Access
- 26 June 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (33) , e15409
Inhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates
Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.
- 26 June 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (33) , e15409
Open AccessInhibition and Formation of Amyloid Fibrils in the Bulk and at the Interface of Biomolecular Condensates
Cells can form open compartments, known as biomolecular condensates, which possess distinct environments and concentrations compared to their surroundings. These biomolecular condensates can modulate biochemical processes, including protein aggregation. Notably, they have been reported to both accelerate and inhibit protein aggregation. Since protein aggregation is often associated with pathological conditions like neurodegenerative diseases, it is crucial to understand the molecular mechanisms underlying the interplay between phase separation and fibril formation. In this review, we discuss how, contrary to intuition, aggregation within the bulk of condensates can be inhibited rather than promoted, even in the presence of elevated local protein concentration. However, biomolecular condensates can still facilitate fibril formation by generating an interface between the dense and dilute phases, where molecular and mesoscale properties are optimal for the nucleation of protein aggregation.
- Open Access
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Competition between protein-RNA clustering and phase separation drives re-entrant phase behavior of hnRNPA1
Phase separation of RNA-binding proteins plays crucial roles in the cell and is modulated by RNA, including promotion and suppression at low and high RNA concentrations, respectively. In complex coacervates, suppression of phase separation is rationalized by charge inversion when increasing the concentration of one component. Here, we show that suppression of biomolecular condensates of the RNA-binding protein hnRNPA1 at high RNA concentration is driven by a different mechanism, namely the competition with formation of nano-sized protein-RNA clusters in the dilute phase. We show that the competition is modulated not only by RNA concentration, but also by the type of RNA, with specific RNA being more effective in promoting cluster formation than unspecific RNA. We further show that protein-RNA clusters convert into amyloid fibrils over a longer time-scale compared to condensates, therefore providing higher kinetic stability. The competition between clustering and phase separation reported in this study could provide a unifying framework to understand the distinct assemblies of hnRNPA1 in the nucleus and the cytoplasm, where the protein is exposed to different types and concentrations of RNA.
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCompetition between protein-RNA clustering and phase separation drives re-entrant phase behavior of hnRNPA1
Phase separation of RNA-binding proteins plays crucial roles in the cell and is modulated by RNA, including promotion and suppression at low and high RNA concentrations, respectively. In complex coacervates, suppression of phase separation is rationalized by charge inversion when increasing the concentration of one component. Here, we show that suppression of biomolecular condensates of the RNA-binding protein hnRNPA1 at high RNA concentration is driven by a different mechanism, namely the competition with formation of nano-sized protein-RNA clusters in the dilute phase. We show that the competition is modulated not only by RNA concentration, but also by the type of RNA, with specific RNA being more effective in promoting cluster formation than unspecific RNA. We further show that protein-RNA clusters convert into amyloid fibrils over a longer time-scale compared to condensates, therefore providing higher kinetic stability. The competition between clustering and phase separation reported in this study could provide a unifying framework to understand the distinct assemblies of hnRNPA1 in the nucleus and the cytoplasm, where the protein is exposed to different types and concentrations of RNA.
- Open Access
Competition between protein-RNA clustering and phase separation drives re-entrant phase behavior of hnRNPA1
Phase separation of RNA-binding proteins plays crucial roles in the cell and is modulated by RNA, including promotion and suppression at low and high RNA concentrations, respectively. In complex coacervates, suppression of phase separation is rationalized by charge inversion when increasing the concentration of one component. Here, we show that suppression of biomolecular condensates of the RNA-binding protein hnRNPA1 at high RNA concentration is driven by a different mechanism, namely the competition with formation of nano-sized protein-RNA clusters in the dilute phase. We show that the competition is modulated not only by RNA concentration, but also by the type of RNA, with specific RNA being more effective in promoting cluster formation than unspecific RNA. We further show that protein-RNA clusters convert into amyloid fibrils over a longer time-scale compared to condensates, therefore providing higher kinetic stability. The competition between clustering and phase separation reported in this study provides a unifying framework to understand the distinct assemblies of hnRNPA1 in the nucleus and the cytoplasm, where the protein is exposed to different types and concentrations of RNA.
Open AccessCompetition between protein-RNA clustering and phase separation drives re-entrant phase behavior of hnRNPA1
Phase separation of RNA-binding proteins plays crucial roles in the cell and is modulated by RNA, including promotion and suppression at low and high RNA concentrations, respectively. In complex coacervates, suppression of phase separation is rationalized by charge inversion when increasing the concentration of one component. Here, we show that suppression of biomolecular condensates of the RNA-binding protein hnRNPA1 at high RNA concentration is driven by a different mechanism, namely the competition with formation of nano-sized protein-RNA clusters in the dilute phase. We show that the competition is modulated not only by RNA concentration, but also by the type of RNA, with specific RNA being more effective in promoting cluster formation than unspecific RNA. We further show that protein-RNA clusters convert into amyloid fibrils over a longer time-scale compared to condensates, therefore providing higher kinetic stability. The competition between clustering and phase separation reported in this study provides a unifying framework to understand the distinct assemblies of hnRNPA1 in the nucleus and the cytoplasm, where the protein is exposed to different types and concentrations of RNA.
- Top Cited PapersOpen Access
- 18 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
Local environment in biomolecular condensates modulates enzymatic activity across length scales
The mechanisms that underlie the regulation of enzymatic reactions by biomolecular condensates and how they scale with compartment size remain poorly understood. Here we use intrinsically disordered domains as building blocks to generate programmable enzymatic condensates of NADH-oxidase (NOX) with different sizes spanning from nanometers to microns. These disordered domains, derived from three distinct RNA-binding proteins, each possessing different net charge, result in the formation of condensates characterized by a comparable high local concentration of the enzyme yet within distinct environments. We show that only condensates with the highest recruitment of substrate and cofactor exhibit an increase in enzymatic activity. Notably, we observe an enhancement in enzymatic rate across a wide range of condensate sizes, from nanometers to microns, indicating that emergent properties of condensates can arise within assemblies as small as nanometers. Furthermore, we show a larger rate enhancement in smaller condensates. Our findings demonstrate the ability of condensates to modulate enzymatic reactions by creating distinct effective solvent environments compared to the surrounding solution, with implications for the design of protein-based heterogeneous biocatalysts.
- 18 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
Top Cited PapersOpen AccessLocal environment in biomolecular condensates modulates enzymatic activity across length scales
The mechanisms that underlie the regulation of enzymatic reactions by biomolecular condensates and how they scale with compartment size remain poorly understood. Here we use intrinsically disordered domains as building blocks to generate programmable enzymatic condensates of NADH-oxidase (NOX) with different sizes spanning from nanometers to microns. These disordered domains, derived from three distinct RNA-binding proteins, each possessing different net charge, result in the formation of condensates characterized by a comparable high local concentration of the enzyme yet within distinct environments. We show that only condensates with the highest recruitment of substrate and cofactor exhibit an increase in enzymatic activity. Notably, we observe an enhancement in enzymatic rate across a wide range of condensate sizes, from nanometers to microns, indicating that emergent properties of condensates can arise within assemblies as small as nanometers. Furthermore, we show a larger rate enhancement in smaller condensates. Our findings demonstrate the ability of condensates to modulate enzymatic reactions by creating distinct effective solvent environments compared to the surrounding solution, with implications for the design of protein-based heterogeneous biocatalysts.
- Open Access
- 12 March 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (7) , 1052-1061
RNA modulates hnRNPA1A amyloid formation mediated by biomolecular condensates
Several RNA binding proteins involved in membraneless organelles can form pathological amyloids associated with neurodegenerative diseases, but the mechanisms of how this aggregation is modulated remain elusive. Here we investigate how heterotypic protein–RNA interactions modulate the condensation and the liquid to amyloid transition of hnRNPA1A, a protein involved in amyothropic lateral sclerosis. In the absence of RNA, formation of condensates promotes hnRNPA1A aggregation and fibrils are localized at the interface of the condensates. Addition of RNA modulates the soluble to amyloid transition of hnRNPA1A according to different pathways depending on RNA/protein stoichiometry. At low RNA concentrations, RNA promotes both condensation and amyloid formation, and the catalytic effect of RNA adds to the role of the interface between the dense and dilute phases. At higher RNA concentrations, condensation is suppressed according to re-entrant phase behaviour but formation of hnRNPA1A amyloids is observed over longer incubation times. Our findings show how heterotypic nucleic acid–protein interactions affect the kinetics and molecular pathways of amyloid formation.
- 12 March 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (7) , 1052-1061
Open AccessRNA modulates hnRNPA1A amyloid formation mediated by biomolecular condensates
Several RNA binding proteins involved in membraneless organelles can form pathological amyloids associated with neurodegenerative diseases, but the mechanisms of how this aggregation is modulated remain elusive. Here we investigate how heterotypic protein–RNA interactions modulate the condensation and the liquid to amyloid transition of hnRNPA1A, a protein involved in amyothropic lateral sclerosis. In the absence of RNA, formation of condensates promotes hnRNPA1A aggregation and fibrils are localized at the interface of the condensates. Addition of RNA modulates the soluble to amyloid transition of hnRNPA1A according to different pathways depending on RNA/protein stoichiometry. At low RNA concentrations, RNA promotes both condensation and amyloid formation, and the catalytic effect of RNA adds to the role of the interface between the dense and dilute phases. At higher RNA concentrations, condensation is suppressed according to re-entrant phase behaviour but formation of hnRNPA1A amyloids is observed over longer incubation times. Our findings show how heterotypic nucleic acid–protein interactions affect the kinetics and molecular pathways of amyloid formation.
- Open Access
- 3 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Local structural preferences in shaping tau amyloid polymorphism
Tauopathies encompass a group of neurodegenerative disorders characterised by diverse tau amyloid fibril structures. The persistence of polymorphism across tauopathies suggests that distinct pathological conditions dictate the adopted polymorph for each disease. However, the extent to which intrinsic structural tendencies of tau amyloid cores contribute to fibril polymorphism remains uncertain. Using a combination of experimental approaches, we here identify a new amyloidogenic motif, PAM4 (Polymorphic Amyloid Motif of Repeat 4), as a significant contributor to tau polymorphism. Calculation of per-residue contributions to the stability of the fibril cores of different pathologic tau structures suggests that PAM4 plays a central role in preserving structural integrity across amyloid polymorphs. Consistent with this, cryo-EM structural analysis of fibrils formed from a synthetic PAM4 peptide shows that the sequence adopts alternative structures that closely correspond to distinct disease-associated tau strains. Furthermore, in-cell experiments revealed that PAM4 deletion hampers the cellular seeding efficiency of tau aggregates extracted from Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy patients, underscoring PAM4’s pivotal role in these tauopathies. Together, our results highlight the importance of the intrinsic structural propensity of amyloid core segments to determine the structure of tau in cells, and in propagating amyloid structures in disease.
- 3 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessLocal structural preferences in shaping tau amyloid polymorphism
Tauopathies encompass a group of neurodegenerative disorders characterised by diverse tau amyloid fibril structures. The persistence of polymorphism across tauopathies suggests that distinct pathological conditions dictate the adopted polymorph for each disease. However, the extent to which intrinsic structural tendencies of tau amyloid cores contribute to fibril polymorphism remains uncertain. Using a combination of experimental approaches, we here identify a new amyloidogenic motif, PAM4 (Polymorphic Amyloid Motif of Repeat 4), as a significant contributor to tau polymorphism. Calculation of per-residue contributions to the stability of the fibril cores of different pathologic tau structures suggests that PAM4 plays a central role in preserving structural integrity across amyloid polymorphs. Consistent with this, cryo-EM structural analysis of fibrils formed from a synthetic PAM4 peptide shows that the sequence adopts alternative structures that closely correspond to distinct disease-associated tau strains. Furthermore, in-cell experiments revealed that PAM4 deletion hampers the cellular seeding efficiency of tau aggregates extracted from Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy patients, underscoring PAM4’s pivotal role in these tauopathies. Together, our results highlight the importance of the intrinsic structural propensity of amyloid core segments to determine the structure of tau in cells, and in propagating amyloid structures in disease.